96772 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses; DNA viruses Parvoviridae, e.g. feline panleukopenia virus, human parvovirus
SYNTHETIC LIVER-TROPIC ADENO-ASSOCIATED VIRUS CAPSIDS AND USES THEREOF
#2SELECTED ADENO-ASSOCIATED VIRUS COMPOSITIONS HAVING PREFERRED BRAIN, SPINAL CORD, AND/OR HEART EXPRESSION LEVELS
#3CAPSID VARIANTS AND METHODS OF USING THE SAME
#4MODIFIED CAPSID PROTEINS FOR ENHANCED DELIVERY OF PARVOVIRUS VECTORS
#5AAV VECTORS FOR RETINAL AND CNS GENE THERAPY
#6CAPSID VARIANTS AND METHODS OF USING THE SAME
#7ANTIBODY-EVADING VIRUS VECTORS
#8CAPSID VARIANTS AND METHODS OF USING THE SAME
#9CAPSID VARIANTS AND METHODS OF USING THE SAME
#10CAPSID VARIANTS AND METHODS OF USING THE SAME
#11CAPSID VARIANTS AND METHODS OF USING THE SAME
#12AAV Vectors Targeted to Oligodendrocytes
#13COMPOSITIONS AND METHODS FOR THE PRODUCTION OF LIBRARIES
#14AAV PRODUCTION SYSTEMS FOR AAV VIRAL PARTICLES WITH IMPROVED INFECTIVITY
#15Antibody-evading virus vectors
#16METHODS TO PRODUCE CHIMERIC ADENO-ASSOCIATED VIRUS/BOCAVIRUS PARVOVIRUS
#17USE OF AN IRAK4 MODULATOR FOR GENE THERAPY
#18AAV CAPSID DESIGNS
#19IMPROVED ADENO-ASSOCIATED VIRUS GENE THERAPY VECTORS
#20Capsid variants and methods of using the same
#21COMPOSITIONS AND METHODS FOR INDUCIBLE ALTERNATIVE SPLICING REGULATION OF GENE EXPRESSION
#22NOVEL ERYTHROPARVOVIRUS ASSOCIATED WITH RESPIRATORY DISTRESS IN EQUINE
#23NOVEL RECOMBINANT ADENO-ASSOCIATED VIRUS CAPSIDS WITH ENHANCED HUMAN PANCREATIC TROPISM
#24TARGETING PEPTIDES FOR DIRECTING ADENO-ASSOCIATED VIRUSES (AAVs)
#25CAPSID-MODIFIED RAAV VECTOR COMPOSITIONS AND METHODS THEREFOR
#26AAV MUTANT HAVING BRAIN-TARGETING PROPERTY
#27Antibodies against disease causing agents of canines and felines and uses thereof
#28Human papilloma virus type 51 L1 protein mutants
#29Modified capsid proteins for enhanced delivery of parvovirus vectors
#30Insect toxin delivery mediated by a densovirus coat protein
#31Antibody-evading virus vectors
#32Methods and compositions for modifying assembly-activating protein (AAP)-dependence of viruses
#33AAV VP1U CHIMERAS
#34ADENO-ASSOCIATED VIRAL CAPSIDS WITH EXPANDED SIZES
#35SYNTHETIC LIVER-TROPIC ADENO-ASSOCIATED VIRUS CAPSIDS AND USES THEREOF
#36Variant adeno-associated viruses and methods of using
#37AAV vectors for retinal and CNS gene therapy
#38SCALABLE METHOD FOR RECOMBINANT AAV PRODUCTION
#39Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
#40Recombinant adeno-associated virus capsids with enhanced human pancreatic tropism
#41Modified capsid proteins for enhanced delivery of parvovirus vectors
#42Methods and compositions for modifying assembly-activating protein (AAP)-dependence of viruses
#43AAV vectors targeted to oligodendrocytes
#44AAV capsid designs
#45Variant adeno-associated viruses and methods of using
#46Insect toxin delivery mediated by a densovirus coat protein
#47Modulators of complement function
#48AAV-ANTI PCSK9 ANTIBODY CONSTRUCTS AND USES THEREOF
#49Mutated structural protein of a parvovirus
#50AAV Vectors Targeted to Oligodendrocytes
#51Targeting peptides for directing adeno-associated viruses (AAVs)
#52AAV vectors for retinal and CNS gene therapy
#53Enhanced AAV-mediated gene transfer for retinal therapies
#54AAV vectors targeted to oligodendrocytes
#55Mutated structural protein of a parvovirus
#56MUTATED STRUCTURAL PROTEIN OF A PARVOVIRUS